Moreover, the transcriptional program of lipogenesis was downregulated by NAG-Drp1si treatment in mice with NASH, as shown by the decrease in Dgat2 and Fasn mRNA levels (Figure 4D). Here, DGAT2 is linked to metabolic dysfunction-associated steatohepatitis.